Chevron Left
Back to Drug Development

Drug Development, University of California San Diego

4.5
213 ratings
36 reviews

About this Course

The University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences Drug Development course brings you lectures from both faculty and industry experts. With this course, recorded on campus at UCSD, we seek to share our access to top people in the field who bring an unprecedented range of expertise on drug development. In this course you will learn the different stages of clinical development as well as the regulatory including but not limited to, an Investigational New Drug Application (IND), New Drug Application (NDA), and product labeling. Additionally you will learn how to Incorporate study design methods for consideration in the design of clinical protocols to assess safety, tolerability, and efficacy in multiple therapeutic areas. In this course you will learn the different phases of clinical development: * Phase 1 or early stage clinical trial are conducted primar­ily to determine how the new drug works in humans, its safety profile and to predict its dosage range. It typically involves between 30 and 100 healthy volunteers. * Phase 2 or Proof of Concept POC studies test for efficacy as well as safety and side effects in a group of between 30 to 200 hundred patients with the disease for which the new drug is being developed. * Phase 3 or late stage clinical development involve much larger group of patients, between a few hundred to thousands, depending on the indication, which will help determine if the new drug can be considered both safe and effective. It will involve control groups using placebo and/or current treatment as a comparison. * Product registration and approval process after a drug is considered safe and effective from Phase 3 trials, it must be authorized in each individual country before it can be marketed. All data gen­erated about the small molecule or biologic is collected and submitted to the regulatory authorities in the US at the FDA, Food and Drug Administration FDA, in Europe the EMA or European Medicines Agency, Japan Ministry of Health and other countries which may require their own national approvals. This course is intended as part 2 of a series: Drug Discovery (https://www.coursera.org/learn/drug-discovery), Drug Development and Drug Commercialization (https://www.coursera.org/learn/drug-commercialization). We would highly recommend that you take the courses in order since it will give you a better understanding on how a drug is discovered in the lab before being tested in clinical trials and then launched in the market place....
Filter by:

35 Reviews

By Philip Riedel

Dec 02, 2018

Fantastic course, learned a lot of new things. Will go for the drug discovery course next. Consider including the presentations before the tests rather than afterwards

By Adrián Posado Fernández

Nov 12, 2018

The course is very informative, specially for people with no experience nor specialized formation in Clinical Trials. However, it is not very detailed nor demanding, so I doubt about its usefulness for someone with previous university formation in clinical research field.

By Heather Grace

Oct 16, 2018

Very well done and informative. I truly appreciate the Drug process in entirety being broken down into sections that are easy to comprehend. It is obvious the speakers were chosen for their knowledge.

By Sourav Mukherjee

Sep 21, 2018

Thank you.

By Damien Veauvy-ext

Sep 17, 2018

good up to phase 2 (included). Phase 3 and after was less informative

By Michael Doyle

Sep 02, 2018

My only comment is minor - I like to print the slides and make notes on them as I listen to each lecture. I have used so much ink up printing them due to them having blue backgrounds etc. It would be good for future courses that the slides can be made just in black and white with minimal use of colour.

By Harish Ravi

Aug 29, 2018

Great course, came up with drug concentration based on half life and also on electronic mental disorder measure based on interview and then direct concentration dose reComendation hypothesis and also thought of non selective cancer cure based on valorproic acid as it suppressed genes and it's expression and division. Also wrote a paper on IQ and jruri muscular strength based on threshold and firing and correlation to neuro schedule H medicine. extremeadventureinc.business.site

By SAMEER ALI

Jul 25, 2018

EXCELLENT COURSE

By Michael Rehman

Jul 19, 2018

Information in the course is very practical. I come from basic biology background and now with this course I gained some real insights about how the clinical trails happen.

By ANTONIOS MARIOS NIKOLAOS CHIONIS

Jun 03, 2018

Excellent! I am rather new in the Drug Development field, this course really helped me onboard and catch up with terminology and a lot of commonly encountered acronyms (IND, NDA etc..) Would highly recommend to those who are new in the field or just want to broaden their knowledge.